Skip to main content
SpringerLink
Log in

PROSTATE CANCER

PRECISION delivers on the PROMIS of mpMRI in early detection

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Use of multiparametric MRI for detection of prostate cancer has been increasing and two recent studies have provided high-quality evidence advocating its integration into the diagnostic protocol. A new paradigm for detection of prostate cancer in the era of PROMIS and PRECISION should be adopted globally.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: The proposed new paradigm for early detection of prostate cancer in the PROMIS and PRECISION era.

References

  1. Moore, C. M. et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur. Urol. 64, 544–552 (2013).

    Article  PubMed  Google Scholar 

  2. Weinreb, J. C. et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur. Urol. 69, 16–40 (2016).

    Article  PubMed  Google Scholar 

  3. Ahmed, H. U. et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389, 815–822 (2017).

    Article  PubMed  Google Scholar 

  4. Kasivisvanathan, V. et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N. Engl. J. Med. 378, 1767–1777 (2018).

    Article  PubMed  Google Scholar 

  5. Panebianco, V. et al. Negative multiparametric magnetic resonance imaging for prostate cancer: what’s next? Eur. Urol. 74, 48–54 (2018).

  6. Murphy, D. G. et al. The Melbourne Consensus Statement on the early detection of prostate cancer. BJU Int. 113, 186–188 (2014).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia

    Tatenda Nzenza & Declan G. Murphy

  2. Sir Peter MacCallum Department of Oncology. University of Melbourne, Parkville, Australia

    Tatenda Nzenza & Declan G. Murphy

Authors
  1. Tatenda Nzenza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Declan G. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Declan G. Murphy.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nzenza, T., Murphy, D.G. PRECISION delivers on the PROMIS of mpMRI in early detection. Nat Rev Urol 15, 529–530 (2018). https://doi.org/10.1038/s41585-018-0046-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-018-0046-5

  • Springer Nature Limited

Search

Navigation